BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23169233)

  • 1. HIPK2: A tumour suppressor that controls DNA damage-induced cell fate and cytokinesis.
    Hofmann TG; Glas C; Bitomsky N
    Bioessays; 2013 Jan; 35(1):55-64. PubMed ID: 23169233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR.
    Winter M; Sombroek D; Dauth I; Moehlenbrink J; Scheuermann K; Crone J; Hofmann TG
    Nat Cell Biol; 2008 Jul; 10(7):812-24. PubMed ID: 18536714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homeodomain-interacting protein kinase 2 is the ionizing radiation-activated p53 serine 46 kinase and is regulated by ATM.
    Dauth I; Krüger J; Hofmann TG
    Cancer Res; 2007 Mar; 67(5):2274-9. PubMed ID: 17332358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How cells switch HIPK2 on and off.
    Sombroek D; Hofmann TG
    Cell Death Differ; 2009 Feb; 16(2):187-94. PubMed ID: 18974774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
    Di Stefano V; Soddu S; Sacchi A; D'Orazi G
    Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma-radiation-induced ATM-dependent signalling in human T-lymphocyte leukemic cells, MOLT-4.
    Tichý A; Záskodová D; Rezácová M; Vávrová J; Vokurková D; Pejchal J; Vilasová Z; Cerman J; Osterreicher J
    Acta Biochim Pol; 2007; 54(2):281-7. PubMed ID: 17565390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells.
    Puca R; Nardinocchi L; Givol D; D'Orazi G
    Oncogene; 2010 Aug; 29(31):4378-87. PubMed ID: 20514025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zyxin is a critical regulator of the apoptotic HIPK2-p53 signaling axis.
    Crone J; Glas C; Schultheiss K; Moehlenbrink J; Krieghoff-Henning E; Hofmann TG
    Cancer Res; 2011 Mar; 71(6):2350-9. PubMed ID: 21248071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIPK2 phosphorylates ΔNp63α and promotes its degradation in response to DNA damage.
    Lazzari C; Prodosmo A; Siepi F; Rinaldo C; Galli F; Gentileschi M; Bartolazzi A; Costanzo A; Sacchi A; Guerrini L; Soddu S
    Oncogene; 2011 Dec; 30(48):4802-13. PubMed ID: 21602882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.
    Powers JT; Hong S; Mayhew CN; Rogers PM; Knudsen ES; Johnson DG
    Mol Cancer Res; 2004 Apr; 2(4):203-14. PubMed ID: 15140942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDM4/HIPK2/p53 cytoplasmic assembly uncovers coordinated repression of molecules with anti-apoptotic activity during early DNA damage response.
    Mancini F; Pieroni L; Monteleone V; Lucà R; Fici L; Luca E; Urbani A; Xiong S; Soddu S; Masetti R; Lozano G; Pontecorvi A; Moretti F
    Oncogene; 2016 Jan; 35(2):228-40. PubMed ID: 25961923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay between Mdm2 and HIPK2 in the DNA damage response.
    Zhang XP; Liu F; Wang W
    J R Soc Interface; 2014 Jul; 11(96):. PubMed ID: 24829283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage.
    Taira N; Nihira K; Yamaguchi T; Miki Y; Yoshida K
    Mol Cell; 2007 Mar; 25(5):725-38. PubMed ID: 17349958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIPK2 knock-down compromises tumor cell efficiency to repair damaged DNA.
    Nardinocchi L; Puca R; Sacchi A; D'Orazi G
    Biochem Biophys Res Commun; 2007 Sep; 361(1):249-55. PubMed ID: 17658469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promotion of DNA repair by nuclear IKKβ phosphorylation of ATM in response to genotoxic stimuli.
    Sakamoto K; Hikiba Y; Nakagawa H; Hirata Y; Hayakawa Y; Kinoshita H; Nakata W; Sakitani K; Takahashi R; Akanuma M; Kamata H; Maeda S
    Oncogene; 2013 Apr; 32(14):1854-62. PubMed ID: 22614018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive phosphorylation of ATM in lymphoblastoid cell lines from patients with ICF syndrome without downstream kinase activity.
    Goldstine JV; Nahas S; Gamo K; Gartler SM; Hansen RS; Roelfsema JH; Gatti RA; Marahrens Y
    DNA Repair (Amst); 2006 Apr; 5(4):432-43. PubMed ID: 16426903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homeodomain-interacting protein kinase 2 regulates DNA damage response through interacting with heterochromatin protein 1γ.
    Akaike Y; Kuwano Y; Nishida K; Kurokawa K; Kajita K; Kano S; Masuda K; Rokutan K
    Oncogene; 2015 Jun; 34(26):3463-73. PubMed ID: 25151962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA double helix unwinding triggers transcription block-dependent apoptosis: a semiquantitative probe of the response of ATM, RNAPII, and p53 to two DNA intercalators.
    Zhang Z; Wang Y; Song T; Gao J; Wu G; Zhang J; Qian X
    Chem Res Toxicol; 2009 Mar; 22(3):483-91. PubMed ID: 19182866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Tyrosine Kinase c-Abl Promotes Homeodomain-interacting Protein Kinase 2 (HIPK2) Accumulation and Activation in Response to DNA Damage.
    Reuven N; Adler J; Porat Z; Polonio-Vallon T; Hofmann TG; Shaul Y
    J Biol Chem; 2015 Jul; 290(27):16478-88. PubMed ID: 25944899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DNA damage response: sensing and signaling.
    McGowan CH; Russell P
    Curr Opin Cell Biol; 2004 Dec; 16(6):629-33. PubMed ID: 15530773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.